Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in Korea.

Yeon Hee ParkVassiliki KarantzaShawna R CalhounSeri ParkSohee LeeJi-Yeon KimJong Han YuSeok Won KimJeong Eon LeeSeok Jin NamGursel AktanMark Marsico

Published in: Breast cancer research and treatment (2021)

Patients with ER-low/HER2- breast cancer had similar clinicopathological characteristics, treatments, and outcomes as patients with TNBC irrespective of disease setting. Further research is needed to understand predictive and prognostic factors associated with ER-low/HER2- disease.

Keyphrases

estrogen receptor
risk factors
breast cancer cells
endoplasmic reticulum
young adults
skeletal muscle
insulin resistance
breast cancer risk